Liver Transplant News and Research

RSS
When a patient presents with end stage liver disease or liver failure he or she may be considered for a liver transplantation. The first step in this is often a rigorous assessment and being placed on a waiting list.
Model G: New patient hospital gown blends style and comfort

Model G: New patient hospital gown blends style and comfort

Researchers find drug combination that reduces risk of skin graft rejection

Researchers find drug combination that reduces risk of skin graft rejection

New treatment regimen for hepatitis C in transplant patients produces promising results

New treatment regimen for hepatitis C in transplant patients produces promising results

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

Reduced chemotherapy exposure after surgery could decrease overall complications

Reduced chemotherapy exposure after surgery could decrease overall complications

New version of Belmont Rapid Infuser to be introduced at ASA 2014

New version of Belmont Rapid Infuser to be introduced at ASA 2014

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Highlights: Hawaii public hospital cuts; La. struggles with state worker health program costs; aging in Ky.

Highlights: Hawaii public hospital cuts; La. struggles with state worker health program costs; aging in Ky.

First Edition: August 14, 2014

First Edition: August 14, 2014

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

University of Chicago adds six new members to governing Board of Trustees

University of Chicago adds six new members to governing Board of Trustees

Researchers to study multi-faceted approaches to address issues of burnout in transplant surgeons

Researchers to study multi-faceted approaches to address issues of burnout in transplant surgeons

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Highlights: Calif. nurse union in contract fight; personhood measure in Colo.; Md. transgender coverage

Highlights: Calif. nurse union in contract fight; personhood measure in Colo.; Md. transgender coverage

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Many liver transplant patients want to be involved in the decision of whether to accept the organ

Many liver transplant patients want to be involved in the decision of whether to accept the organ

Paracetamol safety and osteoarthritis: an interview with Professor David Hunter, University of Sydney

Paracetamol safety and osteoarthritis: an interview with Professor David Hunter, University of Sydney

Telemedicine could improve quality of life of patients with chronic liver diseases

Telemedicine could improve quality of life of patients with chronic liver diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.